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Nonribosomal peptides and polyketides are two large fam-
ilies of natural products that include many clinically valuable 
drugs, such as vancomycin and erythromycin (antibacterial), 
cyclosporin and rapamycin (immunosuppressant), and bleo-
mycin (BLM) and epothilone (antitumor). The biosynthesis of 
nonribosomal peptides and polyketides are catalyzed by nonri-
bosomal peptide synthetases (NRPSs) and polyketide synthases 
(PKSs), respectively. NRPSs and PKSs apparently use a very 
similar strategy for the assembly of these two distinct classes 
of natural products by sequential condensation of amino acids 
and short carboxylic acids, respectively. Both NRPSs and type 
I PKSs are multifunctional proteins that are organized into 
modules. The number and order of modules on each NRPS or 
PKS protein determine the structural variations of the result-
ing peptide and polyketide products. Both systems use carrier 
proteins, peptidyl carrier protein (PCP) for NRPS and acyl car-
rier protein (ACP) for PKS, that are posttranslationally modi-
fi ed with the same 4′-phosphopantetheine prosthetic group to 
channel the growing peptide or polyketide intermediate during 
the elongation processes [2–4,19,30]. The latter modifi cation 
is catalyzed by a family of 4′-phosphopantetheineyl transfer-
ases (PPTases) (Figure 1A) [20,31]. These striking structural 
and catalytic similarities between NRPSs and PKSs support 
the idea of combining individual NRPS and PKS modules into 
hybrid NRPS– PKS systems, in which an NRPS-bound grow-
ing peptidyl intermediate could be directly elongated by a PKS 
module (Figure 1B) or vice versa (Figure 1C) [3,4,8,10]. Since 
the modular architecture of both NRPSs and PKSs has been 
exploited successfully in the combinatorial biosyntheses of di-
verse “unnatural” natural products [2–4], it is imagined that hy-
brid NRPS–PKS systems, capable of incorporating both amino 
acids and short carboxylic acids into the fi nal products, could 
lead to even greater chemical structural diversity. 
We have been studying the biochemistry and genetics of 
BLM biosynthesis in Streptomyces verticillus ATCC15003 
as a model for the biosynthesis of hybrid peptide–polyketide 
natural products [6–10,23,24]. Here we summarize our fi nd-
ings on (1) functional interactions between BLM NRPS and 
PKS modules that represent a natural hybrid NRPS–PKS sys-
tem and (2) posttranslational modifi cation of the BLM me-
gasynthetase by the Svp PPTase that exhibits a broad substrate 
specifi city toward both ACPs and PCPs. These results shed 
light on the molecular basis for a functional hybrid NRPS–
PKS system. 
BLM as an example of natural hybrid peptide–
polyketide metabolites
The BLMs, a family of anticancer antibiotics produced by 
S. verticillus, differ structurally at the C-terminal amines of 
the glycopeptides. The biosynthesis of BLMs has been exten-
sively studied by feeding isotope-labeled precursors [12,27–
29]. These results unambiguously established the hybrid pep-
tide–polyketide origin of the BLMs, the aglycone of which 
is derived from nine amino acids, an acetate, and two methyl 
groups derived from S-adenosyl methionine (AdoMet) (Figure 
2A). Subsequent isolation and structural determination of a 
series of biosynthetic intermediates and shunt metabolites, in-
cluding P-3A, P-4, P-5, and P-6m, from fermentation cultures 
led to the hypothesis of a processive pathway for assembly of 
the BLM hybrid peptide– polyketide backbone (Figure 2B). It 
is noteworthy that such a hybrid peptide–polyketide biosyn-
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thesis model, inspired mainly by the fatty acid synthase, was 
put forward long before the characterization of the modular 
structure of either NRPS or PKS. According to today’s hybrid 
NRPS–PKS model [3,4,8,10], we could easily envisage bio-
synthesis of the BLM aglycone in three stages: (I) NRPS-me-
diated formation of P-3A from Ser, Asn, Asn, His, and Ala, 
(II) PKS-mediated elongation of P-3A by malonyl CoA and 
Adomet to yield P-4, and (III) NRPSmediated elongation of 
P-4 by Thr to P-5 that is further elongated by β-Ala, Cys, and 
Cys to generate P-6m (Figure 2B). Therefore, the transition 
between stage I/II or II/III could potentially represent a natu-
ral hybrid NRPS/PKS (Figure 1B) or PKS/NRPS (Figure 1C) 
system, respectively. 
BLM megasynthetase as an example of natural hy-
brid NRPS–PKS systems
While the feeding experiments and the isolation of vari-
ous biosynthetic and shunt metabolites motivated us to formu-
late the hybrid NRPS–PKS hypothesis for BLM biosynthesis, 
it is the cloning and characterization of the BLM biosynthetic 
gene cluster that provide direct evidence for the existence of 
the BLM megasynthetase, a natural hybrid NRPS–PKS sys-
tem that catalyzes the assembly of the BLM aglycone back-
bone from the amino acid and short carboxylic acid precursors 
[6–10,23,24]. The blm gene cluster consists of 30 genes (Fig-
ure 3A), clustered with the blmA and blmB resistance genes 
that confer BLM resistance by drug sequestering and drug 
modifi cation, respectively. Located in the center of the blm 
gene cluster are 10 NRPS genes encoding nine NRPS mod-
ules and a PKS gene encoding one PKS module. We predicted 
the substrate specifi cities of individual NRPS and PKS mod-
ules based on sequence analysis [5,7,15,26] and subsequently 
confi rmed the amino acid specifi cities of fi ve NRPS modules 
and the malonyl CoA specifi city of the PKS module biochem-
ically in vitro (Figure 3A). 
On the basis of the BLM structure and the deduced func-
tions of individual NRPS and PKS domains and modules, we 
proposed a linear model for the BLM megasynthetase-tem-
plated assembly of the BLM peptide/polyketide/peptide agly-
Figure 1 (A) PPTase-catalyzed posttranslational modifi cation of apo-ACP/PCP into holo-ACP/PCP. (B) Hybrid NRPS/PKS-catalyzed C–C bond 
formation in hybrid peptide/polyketide biosynthesis. (C) Hybrid PKS/ NRPS-catalyzed C–N bond formation in hybrid polyketide/peptide biosynthe-
sis. These are hypothetical NRPS and PKS modules shown with only their respective core domains. Abbreviations for NRPS and PKS domains 
are: A, adenylation; ACP, acyl carrier protein; AT, acyltransferase; C, condensation; KS, ketoacyl synthase; and PCP, peptidyl carrier protein. 
380  SHEN ET AL. IN J. INDUST. MICROBIOL. & BIOTECH. 27 (2001)
cone from nine amino acids and one acetate (Figure 3B) [7]. 
Individual modules are fi rst primed with the amino acid or 
short carboxylic acid precursors, the choice of which is de-
termined by the adenylation (A) domains of the NRPS mod-
ules or the acyltransferase (AT) domain of the PKS module, 
respectively (Figure 3A). The BlmVI, BlmV, BlmX, BlmIXm 
NRPS-mediated N-to-C directional assembly of the pseudo-
pentapeptide intermediate proceeds by sequential condensa-
tion of Ser, Asn, Asn, His, and Ala, as evidenced by the isola-
tion of P-3A (Figure 2B, stage I). In the next step, a malonate 
reacts with the resulting pentapeptide intermediate to form a 
β-ketothioester intermediate that is subsequently methylated 
at the β-position and reduced at the β-keto group, and this pro-
posal is consistent with the isolation of P-4 (Figure 2B, stage 
II). The BlmVIII PKS module presumably dictates all these 
biosynthetic events and interacts with the upstream BlmIX 
NRPS module to channel the growing peptide intermediate 
from an NRPS module to a PKS module. After one cycle of 
polyketide elongation, peptide elongation is resumed by incor-
poration of a Thr residue. This step is catalyzed by the Blm-
VII NRPS module that interacts with the upstream BlmVIII 
PKS module to channel the growing polyketide intermediate 
Figure 2 (A) Structures of BLMs and primary biosynthetic precursors for the BLM aglycone. (B) The proposed biosynthetic pathway for BLMs in-
volved a hybrid NRPS/ PKS/ NRPS system. The growing hybrid peptide–polyketide intermediates P-3A, P-4, P-5, and P-6m were isolated from 
the wild-type S. verticillus fermentation and their structures were determined [12,27– 29]. 
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(as far as the active site is concerned) from a PKS module to 
an NRPS module. Subsequent elongation by three additional 
NRPS modules (BlmIV and BlmIII) incorporates β-Ala and 
two molecules of Cys into the BLM aglycone backbone (Fig-
ure 2B, stage III). Isolation of biosynthetic intermediates such 
as P-5 and P-6m supports the latter proposal. Finally, the fully 
assembled and modifi ed BLM aglycone is released from the 
BLM megasynthetase complex via a nucleophilic substitution 
of the RCO-S-PCP species by an amine, RNH2. In contrast 
to most of the NRPSs and PKSs known to date that release 
the full-length peptide or polyketide intermediate from the 
enzyme complex by a thioesterase domain [2–4], BlmII and 
BlmXI, two discrete condensation enzymes identifi ed within 
the blm gene cluster, have been proposed to catalyze the latter 
step [7]. Similar condensation (C) domain-catalyzed release 
of either RCO-S-PCP from NRPS [18] or RCO-S-ACP from 
PKS [17] has been proposed previously. The isolated biosyn-
thetic intermediates, such as P-4, P-5, and P-5m, presumably 
resulted from premature departure from the BLM megasynthe-
tase complex before the growing chain reaches its full length. 
Intermodular communication between BlmIX/ 
BlmVIII /BlmVII as an example of both hybrid NRPS/
PKS and hybrid PKS/NRPS systems
In peptide biosynthesis, the C–N bond formation is medi-
ated by the C domain that catalyzes nucleophilic substitution 
between the peptidyl-S-PCP from the upstream module, also 
known as “donor site” substrate, and the amino group of its 
cognate amino acyl-S-PCP, also known as “acceptor site” sub-
strate [1,25]. In hybrid polyketide/peptide biosynthesis, how-
ever, the C domain of the hybrid PKS/NRPS mediates the 
same C–N bond formation but by catalyzing the nucleophilic 
substitution between the acyl-S-ACP of the PKS module and 
the amino acyl-S-PCP of the NRPS (Figure 1C). This model 
suggests that the critical domains for functional interaction 
in a hybrid PKS/NRPS system should be the ACP and C do-
Figure 3 (A) Genetic organization of the BLM biosynthetic gene cluster [7]. Modules for individual NRPSand PKSare given along with their pre-
dicted or confi rmed substrates (*) in parentheses. Three-letter amino acid designations were used. B, BamHI. (B) A linear model for the BLM me-
gasynthetase-templated assembly of the BLM peptide/polyketide/peptide aglycone from nine amino acids and one acetate [7]. Abbreviations for 
NRPSand PKS domains are: A, adenylation; ACP, acyl carrier protein; AL, acyl CoA ligase; AT, aclytransferase; C and C′, condensation; Cy, con-
densation/ cyclization; KR, ketoreductase; KS, ketoacyl synthase; MT, methyltransferase; Ox, oxidation; and PCP, peptidyl carrier protein. “NH2,” 
an unspecifi ed amino group donor. 
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mains of the PKS and NRPS modules, respectively. While the 
acceptor site substrate of amino acyl-S-PCP remains the same, 
the C domain in a hybrid PKS/ NRPS has to differentiate the 
donor site substrate of acyl-S-ACP for polyketide/peptide bio-
synthesis from peptidyl-S-PCP for peptide biosynthesis. 
In polyketide biosynthesis, the C–C bond formation is me-
diated by the KS domain that catalyzes (1) the transfer of the 
acyl-S-ACP from the upstream module, the donor site sub-
strate, to the active site cysteine of KS and (2) the decarbox-
ylative condensation between the resulting acyl-S-KS and its 
cognate malonyl-S-ACP, the acceptor site substrate [2– 4]. 
(Both “donor site” and “acceptor site” substrates for PKS are 
defi ned in a mechanistic analogy to NRPS [1].) In hybrid pep-
tide/polyketide biosynthesis, however, the KS domain of the 
hybrid NRPS/PKS mediates the same C–C bond formation 
but by catalyzing transfer of the peptidyl-S-PCP from the up-
stream NRPS module to the active site cysteine of KS to form 
a peptidyl-S-KS species. The latter then undergoes similar de-
carboxylative condensation with its cognate malony-S-ACP to 
yield the hybrid peptide/polyketide product (Figure 1B). Ac-
cording to this model, the critical domains for functional in-
teraction in a hybrid NRPS/PKS should be the PCP and KS 
domains of the NRPS and PKS modules, respectively. While 
the acceptor site substrate of malonyl-S-ACP remains the 
same, the KS domain in a hybrid NRPS/PKS has to differenti-
ate the donor site substrate of peptidyl-S-PCP for hybrid pep-
tide/polyketide biosynthesis from acyl-S-ACP for polykeptide 
biosynthesis. 
Many bacterial genomes encode multiple peptide and/
or polyketide pathways, each of which is composed of mul-
tiple PKS or NRPS modules. However, there is no evidence 
for crosstalk either among NRPS or PKS modules or between 
NRPS or PKS modules that belong to different peptide or 
polyketide pathways. In fact, NRPS or PKS modules consti-
tute the NRPS or PKS megasynthetase with a precise selec-
tivity, as evidenced by the fact that most of the NRPS or PKS 
pathways often produce only one major peptide or polyketide 
product out of a myriad of possibilities. These observations 
suggest the existence of extensive intermodular communi-
cation among modules that constitute the NRPS or PKS me-
gasynthetases, raising an interesting question of how NRPS 
and PKS modules communicate to form hybrid NRPS–PKS 
Figure 4 Schematic representation of the BlmIX/BlmVIII/BlmVII system as a model for channeling the growing intermediate between NRPS and 
PKSmodule s or between PKSand NRPSmodules for biosynthesis of hybrid peptide–polyketide natural products. The KS and ACP domains of Blm 
VIII and the putative interpolypeptide linkers between BlmIX/BlmVIII and BlmVIII/BlmVII are shaded to emphasize their roles in facilitating interac-
tions between NRPSand PKSto constitute a functional hybrid NRPS–PKSsystem. 
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systems. BlmIX/BlmVIII/BlmVII constitutes a natural hybrid 
NRPS/PKS/NRPS system, combining features of both hybrid 
NRPS/PKS and PKS/NRPS systems. We, therefore, reasoned 
that a detailed comparison of BlmIX/BlmVIII/BlmlVII with 
NRPS and PKS modules in nonhybrid systems could shed 
light on the mechanism for NRPS and PKS modules to consti-
tute either hybrid NRPS/PKS or PKS/NRPS systems. 
For BlmIX/BlmVIII, we found that the PCP domain of 
BlmIX seems to have no relevant difference compared to 
those in nonhybrid NRPS systems. In contrast, the KS domain 
of BlmVIII is unique in comparison with those in nonhybrid 
PKS systems. Upon phylogenic analysis, the KS domain of 
BlmVIII can be grouped into a subfamily of KSs from all 
other known hybrid NRPS/PKS systems regardless of their 
origins. Therefore, the BlmVIII PKS may have evolved a KS 
domain with an altered donor site substrate specifi city to adapt 
the BlmIX-bound peptidyl-S-PCP intermediate (Figure 4, step 
a). Once the peptidyl intermediate is transferred to the active 
site cysteine of the KS domain, BlmVIII appears to utilize the 
same catalytic sites conserved in all other PKS domains to ex-
ecute the decarboxylative condensation with the acceptor sub-
strate of malonyl-S-ACP (Figure 4, step b) and the associated 
modifi cations (Figure 4, steps c and d) to yield the resultant 
peptide/polyketide product [7,8]. 
For BlmVIII/BlmVII, we found that the ACP domain of 
BlmVIII is more similar to PCPs than to ACPs but the C do-
main of BlmVII shows no unique features compared to those 
in nonhybrid NRPSs [7,8]. These fi ndings are in accordance 
with (1) the proposed function for the carrier proteins of 
both PKS and NRPS as workstations without any selectivity 
[11,16] and (2) the low selectivity of the NRPS C domain to-
ward the donor site substrate [1]. Physical proximity of the ac-
tive sites may be suffi cient for the C domain to accept the do-
nor site substrate of acyl-S-ACP, instead of peptidyl-S-PCP, 
and to catalyze its elongation with the acceptor site substrate 
of amino acyl-S-PCP to afford the hybrid polyketide/peptide 
product (Figure 4, step e) [7,8]. 
Intermodular communications in PKS have been attrib-
uted to either intermodular linkers that exist between modules 
within a protein or interpolypeptide linkers that exist between 
modules residing on separate proteins [13,14]. Polyketide 
chain transfer between modules appears to be permissive as 
long as the linkers can provide the connectivity between the 
adjacent modules [14]. Inspired by the linker hypothesis for 
PKS, we carried out similar sequence analyses for hybrid 
NRPS–PKS systems with the intention of identifying analo-
gous linkers [8]. It is hoped that the specifi cities of the linkers 
between nonhybrid NRPS or PKS systems and hybrid NRPS–
PKS systems may provide insight into the evolution of NRPS 
and PKS modules into hybrid NRPS–PKS systems. We have 
indeed identifi ed putative interpolypeptide linkers for both hy-
brid NRPS/PKS and hybrid PKS/NRPS systems. They are lo-
cated at the C-termini of the NRPS proteins and N-terminal of 
the PKS proteins for hybrid NRPS/PKS systems and the C-ter-
mini of the PKS proteins and N-termini of the NRPS proteins 
for PKS/NRPS systems. The linkers vary from 5 to 76 amino 
acids and are rich in acidic residues [8]. It is tempting to pro-
pose that these linkers may play a critical role in protein–pro-
tein recognition to constitute a functional hybrid NRPS–PKS 
system, as depicted for BlmIX/ BlmVIII/BlmVII (Figure 4). 
However, the latter conclusion is based purely on sequence 
analysis and has to be assessed experimentally in the future. 
Posttranslational modifi cation of the carrier pro-
teins of hybrid NRPS–PKS systems by a PPTase 
with broad substrate specifi city
For NRPS and PKS to be functional, their carrier proteins 
must be converted from the apo forms to the holo forms by 
covalent attachments of the 4′-phosphopantetheine group to 
an absolutely conserved serine residue. This posttranslational 
modifi cation is catalyzed by a superfamily of enzymes known 
as PPTases that derive the 4′-phosphopantetheine group from 
coenzyme A (CoA) (Figure 1A) [20,31]. Most of the PPTases 
characterized to date exhibit high specifi city toward the car-
rier protein substrates, leading to the proposal that each 4′-
phosphopantetheine-requiring pathway has its own post-
translational modifying PPTase activity [31]. However, a 
functional hybrid NRPS–PKS system requires a PPTase that 
is capable of modifying the apo forms of both PCP and ACP 
into their holo forms. Because all PPTases characterized to 
date are associated with fatty acid, polyketide, or peptide bio-
synthetic pathways, we were particularly interested in fi nding 
out if a PPTase from organisms that produce hybrid peptide– 
polyketide natural products exhibits relaxed specifi city toward 
both ACPs and PCPs. 
Most of the PPTases known to date were identifi ed ei-
ther by association with a peptide or polyketide biosynthetic 
gene cluster or by whole genome sequencing. Sequence anal-
ysis of the blm biosynthetic gene cluster, however, failed to 
reveal an associated PPTase gene, suggesting that the blm 
NRPS and PKS genes are not clustered with their PPTase 
gene [7]. To clone a PPTase gene from S. verticillus, we de-
veloped a PCR method using primers designed according to 
two conserved motifs among PCP-specifi c PPTases of acti-
nomycete origin. The cloned Svp PPTase gene is mapped to 
an independent locus not clustered with any of the NRPS or 
PKS loci previously known to S. verticillus, including the 
blm hybrid peptide–polyketide gene cluster. The Svp protein 
was overproduced in E. coli, purifi ed to homogeneity, and de-
termined to be a monomer in solution. We have been able to 
show that Svp can effi ciently 4′-phosphopantetheinate both 
type I and type II ACPs and PCPs from either S. verticillus 
or other Streptomyces species [23]. As compared to Sfp, the 
only other PPTase known to accept ACPs, ArCPs, and PCPs 
from various organisms, Svp displays a similar catalytic effi -
ciency for PCPs but a 345-fold increase in catalytic effi ciency 
for the tested ACP. Sfp, isolated from Bacillus subtilis, is clus-
tered with the biosynthetic genes for the nonribosomal peptide 
antibiotic surfactin [21]. Sfp has been called a “promiscuous” 
PPTase, because (1) all other known PPTases, associated with 
fatty acid, peptide or polyketide biosynthetic gene clusters, 
are specifi c for their respective ACPs or PCPs, and (2) surfac-
tin biosynthesis does not require the participation of an ACP 
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[20–22,31]. In contrast, we argued that the broad substrate 
specifi city of Svp toward various carrier proteins is an intrin-
sic property for PPTases that are generally responsible for sec-
ondary metabolite biosynthesis. These PPTases are nonessen-
tial for the producing organisms and, therefore, may evolve 
new or broad substrate specifi city toward their carrier proteins 
including both PCPs and ACPs for hybrid peptide– polyketide 
biosynthesis [23]. Although we have shown that S. verticillus 
appears to have evolved a single PPTase, Svp, to posttrans-
lationally modify the BLM hybrid NRPS–PKS system, it is 
yet to be determined if a PPTase with a broad carrier protein 
specifi city is a general solution to provide functional hybrid 
NRPS–PKS systems for hybrid peptide–polyketide natural 
product biosynthesis. 
Concluding remarks
BLM is an example of hybrid peptide–polyketide nat-
ural products. The peptide/polyketide/peptide backbone of 
the BLM aglycone is assembled by the BLM megasynthe-
tase that consists of both NRPS and PKS modules. BlmIX/
BlmVIII /BlmVII constitute a natural hybrid NRPS/PKS and 
PKS/NRPS system, catalyzing the elongation of a peptidyl in-
termediate with a short carboxylic acid and a polyketide in-
termediate with an amino acid. This system therefore serves 
as a model for both hybrid NRPS/ PKS and PKS/NRPS sys-
tems. While biochemical data are still lacking, sequence anal-
ysis and functional comparison of domains and modules of 
BlmIX/BlmVIII /BlmVII with those of nonhybrid NRPS and 
PKS systems are beginning to shed light on hybrid peptide–
polyketide biosynthesis. The same catalytic sites appear to be 
conserved in both hybrid NRPS–PKS and nonhybrid NRPS or 
PKS systems, with the exception of the KS domains in the hy-
brid NRPS/PKS systems that are unique. Specifi c linkers, con-
fi rmed for PKS [13,14], and proposed for NRPS and hybrid 
NRPS–PKS systems [8], may play a critical role in intermod-
ular communication to facilitate the transfer of the growing 
intermediates between the interacting NRPS and/or PKS mod-
ules. In order to be functional, hybrid NRPS–PKS systems re-
quire PPTases that should be capable of posttranslationally 
modifying the apo forms of both PCP and ACP into their holo 
forms. For the BLM megasynthetase, this modifi cation has 
been accomplished by evolving a single PPTase, Svp, with a 
broad substrate specifi city toward the apo forms of both ACPs 
and PCPs. These fi ndings should now help us to formulate re-
search ideas and experimental strategies for studying the bio-
synthesis of hybrid peptide– polyketide natural products. 
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